Investment Thesis
PetMed Express is in severe financial distress with accelerating revenue decline (-21.1% YoY), massive operating losses (-$58.7M), and negative operating cash flow (-$28.4M), indicating the business model is broken. Liquidity ratios below 1.0 combined with ongoing cash burn suggest the company will exhaust its $21.4M cash reserves within 12-24 months without dramatic operational improvements.
Strengths
- Positive gross margin of 28.1% indicates base business model has merit
- No long-term debt eliminates immediate solvency risk from maturity obligations
- Cash reserves of $21.4M provide near-term runway for operational adjustments
Risks
- Revenue declining 21.1% YoY with no stabilization evidence suggests structural market decline or competitive loss
- Operating margin of -32.8% and net margin of -32.0% indicates severe operating leverage failure and cost structure misalignment
- Negative operating cash flow of -$28.4M and FCF of -$33.0M means company is destroying shareholder value and burning reserves unsustainably
- Current ratio of 0.84x and quick ratio of 0.58x indicate liquidity stress and potential inability to meet short-term obligations
- Zero insider buying in 90 days suggests management has no confidence in turnaround prospects
Key Metrics to Watch
- Operating cash flow return to positive territory as prerequisite for viability
- Revenue stabilization and return to growth within 2-3 quarters
- Operating margin improvement and path to positive net income
- Monthly cash burn rate and runway until insolvency without strategic action
- Management announcements regarding restructuring, asset sales, or strategic alternatives
Financial Metrics
Revenue
179.0M
Net Income
-57.3M
EPS (Diluted)
$-2.74
Free Cash Flow
-33.0M
Total Assets
81.2M
Cash
21.4M
Profitability Ratios
Gross Margin
28.1%
Operating Margin
-32.8%
Net Margin
-32.0%
ROE
-197.9%
ROA
-70.6%
FCF Margin
-18.4%
Balance Sheet & Liquidity
Current Ratio
0.84x
Quick Ratio
0.58x
Debt/Equity
0.00x
Debt/Assets
64.4%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-06-04T07:43:00.387706 |
Data as of: 2026-03-31 |
Powered by Claude AI